ARTICLE SUMMARY:
In this week’s Pathways’ Picks, the device industry wants better alignment in Europe on how to deal with clinical trials delayed by COVID-19, Health Canada takes another step toward harmonized electronic submissions, China issues human factors draft guidance, and more global updates.
The device industry is seeking flexibility on EU Post Market Clinical Follow-up (PMCF) requirements and more harmonized guidance throughout Europe for conducting clinical investigations during the COVID-19 outbreak, leading our latest roundup of Pathways’ Picks.
